(Q44025966)

English

Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Robert Lambkin-Williams

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Carr J

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Ives J

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kelly L

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Oxford J

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Mendel D

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Tai L

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Roberts N

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Antiviral Research

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

79-88

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Influenza virus neuraminidase: structure, antibodies, and inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900215-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900215-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900215-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900215-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance of influenza viruses to neuraminidase inhibitors--a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900215-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900215-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900215-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900215-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900215-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900215-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral oseltamivir treatment of influenza in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900215-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Position statement: global neuraminidase inhibitor susceptibility network

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900215-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0166-3542(01)00215-7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44025966&oldid=2105753418"